Purchase Order 75N92B20P00059

Otogenetics Corporation, a minority-owned, small disadvantaged business, has been awarded a $24,849 firm-fixed-price purchase order contract by the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases. The contract, which is not set aside for any specific business category, is for the provision of next-generation sequencing laboratory services, including whole exome sequencing, clinical genetic testing, and data analysis, to support research...

Microgenics Corporation, a clinical diagnostics division of Thermo Electron Corporation, has been awarded a firm fixed price delivery order valued at $22,560.20 from the Defense Health Agency. The order is being issued under an indefinite-delivery contract vehicle to provide opiates reagent kits in support of substance abuse testing and treatment programs across military medical facilities. Performance will take place in Fremont, California through August 2023. As a long-time supplier of...

This federal contract award with ID 75N90019P00629 was issued by the National Institutes of Health (NIH) Clinical Center to Cell Line Genetics, Inc. for $11,200.00. The contract is for a firm fixed-price purchase order with a performance period ending on June 30, 2020. The contract was not set aside for any special type of business. Cell Line Genetics, Inc. is a for-profit organization that is minority-owned, woman-owned, and Hispanic American-owned. This award appears to be related to a...

This federal contract award was issued by the National Institutes of Health (NIH) Clinical Center to PreventiOnGenetics LLC, a for-profit limited liability company specializing in genetic testing services. The $9,700 Firm Fixed Price Purchase Order contract has an ultimate completion date of April 30, 2019. PreventiOnGenetics is an experienced provider of genetic analysis services to federal agencies, holding several Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs and...

Microgenics Corporation, a clinical diagnostics division of Thermo Electron Corporation, has received a $10,412.40 firm fixed price delivery order from the Defense Health Agency to provide NEW- DRI OPIATES IMMUNOASSAY. The order is being performed under an existing contract vehicle without a set-aside designation. It will support substance abuse testing and treatment programs across military medical facilities by supplying opiate immunoassay reagent test kits for use in laboratories located at...

Microgenics Corporation, a clinical diagnostics division of Thermo Electron Corporation, has received a firm fixed price delivery order from the Department of the Navy Bureau of Medicine and Surgery for $15,618.24. The order is for DRI OXYCODONE 500ML with an expected completion date of August 2, 2023. Microgenics will fulfill the order from its location in Fremont, California, leveraging the resources of parent company Thermo Electron Corporation as needed. No set-aside designation or major...

Genedx, LLC was awarded a $10.5K firm fixed-price call under a Blanket Purchase Agreement (BPA) by the National Cancer Institute for germline mutation testing and variant validation in inherited bone marrow failure syndromes. The contract, awarded on July 12, 2018, with an ultimate completion date of May 22, 2023, represents a specialized procurement supporting the NCI's research and clinical objectives. The work was performed at Genedx's laboratory facilities in Potomac, Maryland. This award...

This firm fixed-price purchase order was awarded to Novogene Corporation Inc., a minority-owned small business, by the National Institute of Child Health and Human Development for gene expression profiles (Alirocumab neuroinflammation apoptosis) in the amount of $54,080.00. The award is not associated with a set-aside and is based on a competitive solicitation for providing and analyzing gene expression and complete DNA library preparation, NovaSeq PSK9 (sequencing), and customized analysis....

Microgenics Corporation, a clinical diagnostics subsidiary of Thermo Electron Corporation, was awarded a $347,408.50 firm fixed-price definitive contract by the Court Services and Offender Supervision Agency (CSOSA) Pretrial Services Agency on May 20, 2015. The contract, which ultimately completed on May 11, 2020, procures reagents, calibrators, and quality control supplies for the toxicology laboratory supporting the agency's pretrial services operations in Washington, DC. No set-aside...

Genedx, LLC, a division of Opko Health, Inc., has been awarded a $25,000 firm fixed price purchase order by the National Institutes of Health's National Human Genome Research Institute to provide exome and genome sequencing with optional mitochondrial testing for various patients. The contract has a period of performance of just over one year, running from September 2023 through August 2024. Genedx will perform the sequencing and testing services at its laboratory location in Montgomery Village,...